23948sdkhjf
  • {{ window.visitor.corporateClient.name }}
    Företagslösning
    {{ window.visitor.ipAccess.corporateClient.name }}
    {{ window.visitor.corporateClient.name }}

  • Välkommen till vår företagslösning

    Här kan du administrera användarna i din företagslösning.

  • Welcome to our Corporate client solution

    Your IP is registered with the company mentioned above and provides access to Life Science Sweden.

  • Click here to go to sign-up
Logga in eller skapa en prenumeration för att spara artiklar
Få tillgång till allt innehåll på Life Science Sweden
Ingen bindningstid eller kortinformation krävs
Prova Life Science Sweden nu
Gäller endast personlig prenumeration.
Kontakta oss för en företagslösning.
Annons
Annons

Investor Network Backs Early-Stage Nordic Innovation

Life Science Invest is expanding into the Nordic region and has secured SEK 31 million to invest in early-stage research companies. The capital will be invested in around ten life science companies over the coming year.
Annons

Life Science Invest describes itself as Sweden’s largest network of private investors in life science. One of its companies, LSI Zeta, has now raised SEK 31 million from 35 Nordic investors to support early-stage research companies across the region.

Speaking to Life Science Sweden, Kristofer Klerfalk, CEO of LSI Zeta, says the capital will be invested in eight to ten Nordic companies at the pre-seed and seed stages, within biotech, medtech and deeptech in life science.

Annons Annons
BREAKING
{{ article.headline }}
0.063|